Below are the top 10 most profitable Biotech stocks for the last 12 months. One
Chinese company (CPHI) is on the list. Momenta Pharmaceuticals, Inc.
(NASDAQ:MNTA) is the 1st most profitable stock in this segment of the market.
Its net profit margin was 68.72% for the last 12 months. Its operating profit
margin was 68.30% for the same period. Transition Therapeutics Inc.
(NASDAQ:TTHI) is the 2nd most profitable stock in this segment of the market.
Its net profit margin was 43.49% for the last 12 months. Its operating profit
margin was 43.49% for the same period. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)
is the 3rd most profitable stock in this segment of the market. Its net profit
margin was 43.42% for the last 12 months. Its operating profit margin was 45.16%
for the same period. InterMune, Inc. (NASDAQ:ITMN) is the 4th most profitable
stock in this segment of the market. Its net profit margin was 42.25% for the
last 12 months. Its operating profit margin was 44.46% for the same period.
Techne Corporation (NASDAQ:TECH) is the 5th most profitable stock in this
segment of the market. Its net profit margin was 38.73% for the last 12 months.
Its operating profit margin was 56.23% for the same period. PDL BioPharma Inc.
(NASDAQ:PDLI) is the 6th most profitable stock in this segment of the market.
Its net profit margin was 35.39% for the last 12 months. Its operating profit
margin was 65.41% for the same period. Osiris Therapeutics, Inc. (NASDAQ:OSIR)
is the 7th most profitable stock in this segment of the market. Its net profit
margin was 34.96% for the last 12 months. Its operating profit margin was 32.51%
for the same period. Gilead Sciences, Inc. (NASDAQ:GILD) is the 8th most
profitable stock in this segment of the market. Its net profit margin was 34.78%
for the last 12 months. Its operating profit margin was 47.24% for the same
period. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is the 9th most profitable
stock in this segment of the market. Its net profit margin was 32.45% for the
last 12 months. Its operating profit margin was 32.23% for the same period.
China Pharma Holdings, Inc. (AMEX:CPHI) is the 10th most profitable stock in
this segment of the market. Its net profit margin was 29.88% for the last 12
months. Its operating profit margin was 30.89% for the same period.
No comments:
Post a Comment